(ACR2014) Another Rheumatology Network Editorial Board member weighs in: Christopher Collins MD saw reason for great encouragement in a report about an interferon-α blocker for systemic lupus erythematosus.
(AUDIO) A gene defect that causes lupus-like symptoms in a mouse model has turned up as significant in some humans with lupus nephritis, offering a path toward predictive testing. Listen as the lead author reporting this study describes its findings and a timeline toward clinical applications.
(AUDIO) Dr. Mark Shlomchik has won the first $200,000 Insight Prize for research that led toward new lupus drugs such as belimumab. In a brief recorded interview, hear how the award may help him find an explanation for the links between infection and lupus.